Potential Therapeutic Targets of B7 Family in Colorectal Cancer

Programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) pathway blockade has impressively benefited cancer patients with a wide spectrum of tumors. However, its efficacy in colorectal cancer (CRC) is modest, and only a small subset of patients benefits from approved checkpoint inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Changgang, Feng, Haoran, Cheng, Xi, Liu, Kun, Cai, Dongli, Zhao, Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232583/
https://www.ncbi.nlm.nih.gov/pubmed/32477326
http://dx.doi.org/10.3389/fimmu.2020.00681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232583/
https://www.ncbi.nlm.nih.gov/pubmed/32477326
http://dx.doi.org/10.3389/fimmu.2020.00681

Ejemplares similares